Resultados da pesquisa - Boo, Irene
- A mostrar 1 - 12 resultados de 12
-
1
-
2
A Conserved Gly(436)-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry Por Drummer, Heidi E., Boo, Irene, Maerz, Anne L., Poumbourios, Pantelis
Publicado em 2006Text -
3
-
4
-
5
Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine Por Center, Rob J., Boo, Irene, Phu, Lilian, McGregor, Joey, Poumbourios, Pantelis, Drummer, Heidi E.
Publicado em 2020Text -
6
An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry Por McCaffrey, Kathleen, Boo, Irene, Owczarek, Catherine M., Hardy, Matthew P., Perugini, Matthew A., Fabri, Louis, Scotney, Pierre, Poumbourios, Pantelis, Drummer, Heidi E.
Publicado em 2017Text -
7
Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes Por Gu, Jun, Hardy, Joshua, Boo, Irene, Vietheer, Patricia, McCaffrey, Kathleen, Alhammad, Yousef, Chopra, Abha, Gaudieri, Silvana, Poumbourios, Pantelis, Coulibaly, Fasséli, Drummer, Heidi E.
Publicado em 2018Text -
8
Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs Por McGregor, Joey, Hardy, Joshua M., Lay, Chan-Sien, Boo, Irene, Piontek, Michael, Suckow, Manfred, Coulibaly, Fasséli, Poumbourios, Pantelis, Center, Rob J., Drummer, Heidi E.
Publicado em 2022Text -
9
The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs Por Vietheer, Patricia T., Boo, Irene, Gu, Jun, McCaffrey, Kathleen, Edwards, Stirling, Owczarek, Catherine, Hardy, Matthew P., Fabri, Louis, Center, Rob J., Poumbourios, Pantelis, Drummer, Heidi E.
Publicado em 2017Text -
10
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence Por Hartley, Gemma E., Edwards, Emily S.J., Aui, Pei M., Varese, Nirupama, Stojanovic, Stephanie, McMahon, James, Peleg, Anton Y., Boo, Irene, Drummer, Heidi E., Hogarth, P. Mark, O’Hehir, Robyn E., van Zelm, Menno C.
Publicado em 2020Text -
11
Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection Por Drummer, Heidi E, Van, Huy, Klock, Ethan, Zheng, Shuning, Wei, Zihui, Boo, Irene, Center, Rob J, Li, Fan, Bhat, Purnima, Ffrench, Rosemary, Lau, Jillian SY, McMahon, James, Laeyendecker, Oliver, Fernandez, Reinaldo E., Manabe, Yukari C., Klein, Sabra L., Quinn, Thomas C., Anderson, David A.
Publicado em 2021Text -
12
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2 Por Fulford, Thomas S., Van, Huy, Gherardin, Nicholas A., Zheng, Shuning, Ciula, Marcin, Drummer, Heidi E., Redmond, Samuel, Tan, Hyon-Xhi, Boo, Irene, Center, Rob J., Li, Fan, Grimley, Samantha L., Wines, Bruce D., Nguyen, Thi H.O., Mordant, Francesca L., Ellenberg, Paula, Rowntree, Louise C., Kedzierski, Lukasz, Cheng, Allen C., Doolan, Denise L., Matthews, Gail, Bond, Katherine, Hogarth, P. Mark, McQuilten, Zoe, Subbarao, Kanta, Kedzierska, Katherine, Juno, Jennifer A., Wheatley, Adam K., Kent, Stephen J., Williamson, Deborah A., Purcell, Damian F.J., Anderson, David A., Godfrey, Dale I.
Publicado em 2021Text